» Articles » PMID: 22091606

Mechanisms of Toxoplasma Gondii Persistence and Latency

Overview
Specialty Microbiology
Date 2011 Nov 19
PMID 22091606
Citations 131
Authors
Affiliations
Soon will be listed here.
Abstract

Toxoplasma gondii is an obligate intracellular protozoan parasite that causes opportunistic disease, particularly in immunocompromised individuals. Central to its transmission and pathogenesis is the ability of the proliferative stage (tachyzoite) to convert into latent tissue cysts (bradyzoites). Encystment allows Toxoplasma to persist in the host and affords the parasite a unique opportunity to spread to new hosts without proceeding through its sexual stage, which is restricted to felids. Bradyzoite tissue cysts can cause reactivated toxoplasmosis if host immunity becomes impaired. A greater understanding of the molecular mechanisms orchestrating bradyzoite development is needed to better manage the disease. Here, we will review key studies that have contributed to our knowledge about this persistent form of the parasite and how to study it, with a focus on how cellular stress can signal for the reprogramming of gene expression needed during bradyzoite development.

Citing Articles

Increased Herpes simplex virus 1, Toxoplasma gondii and Cytomegalovirus antibody concentrations in severe mental illness.

Andreou D, Steen N, Jorgensen K, Ueland T, Wortinger L, Morch-Johnsen L Transl Psychiatry. 2024; 14(1):498.

PMID: 39695093 PMC: 11655861. DOI: 10.1038/s41398-024-03198-y.


Association of Maternal Molecular and Serological Positivity With Child's Gross-Motor Development and Behavior in Tribal Regions of Gujarat, India: A Prospective Study.

Sundararajan A, Vora K, Saiyed S, Natesan S, Vaidya V Health Sci Rep. 2024; 7(11):e70183.

PMID: 39540024 PMC: 11558262. DOI: 10.1002/hsr2.70183.


A bioinformatic approach for the prediction and functional classification of Toxoplasma gondii long non-coding RNAs.

Vanagas L, Cristaldi C, La Bella G, Ganuza A, Angel S, Alonso A Sci Rep. 2024; 14(1):27687.

PMID: 39533086 PMC: 11557611. DOI: 10.1038/s41598-024-79204-6.


Lipophilic bisphosphonates reduced cyst burden and ameliorated hyperactivity of mice chronically infected with .

Sleda M, Pitafi Z, Song W, Oldfield E, Moreno S mBio. 2024; 15(11):e0175624.

PMID: 39387586 PMC: 11558998. DOI: 10.1128/mbio.01756-24.


Heterologous immunization targeting the CST1 antigen confers better protection than ROP18 in mice.

Eom G, Chu K, Mao J, Yoon K, Kang H, Moon E Nanomedicine (Lond). 2024; 19(29):2437-2446.

PMID: 39320318 PMC: 11520538. DOI: 10.1080/17435889.2024.2403333.


References
1.
Toursel C, Dzierszinski F, Bernigaud A, Mortuaire M, Tomavo S . Molecular cloning, organellar targeting and developmental expression of mitochondrial chaperone HSP60 in Toxoplasma gondii. Mol Biochem Parasitol. 2001; 111(2):319-32. DOI: 10.1016/s0166-6851(00)00324-8. View

2.
Ferguson D, Parmley S, Tomavo S . Evidence for nuclear localisation of two stage-specific isoenzymes of enolase in Toxoplasma gondii correlates with active parasite replication. Int J Parasitol. 2002; 32(11):1399-410. DOI: 10.1016/s0020-7519(02)00129-7. View

3.
Suzuki Y, Wang X, Jortner B, Payne L, Ni Y, Michie S . Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am J Pathol. 2010; 176(4):1607-13. PMC: 2843452. DOI: 10.2353/ajpath.2010.090825. View

4.
Yap G, Scharton-Kersten T, Ferguson D, Howe D, Suzuki Y, Sher A . Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondii. Infect Immun. 1998; 66(9):4382-8. PMC: 108529. DOI: 10.1128/IAI.66.9.4382-4388.1998. View

5.
Painter H, Campbell T, Llinas M . The Apicomplexan AP2 family: integral factors regulating Plasmodium development. Mol Biochem Parasitol. 2010; 176(1):1-7. PMC: 3026892. DOI: 10.1016/j.molbiopara.2010.11.014. View